Press Releases - 2021-05-20

Date	Title	Company
20-May-2021	Original-Research: Formycon AG (von First Berlin Equity Research GmbH)	Formycon AG
20-May-2021	Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Performance and Enhanced Ease of Use	Lonza Group AG
20-May-2021	New Fasenra data from the MELTEMI extension trial confirm long-term safety and efficacy in severe eosinophilic asthma for up to five years	AstraZeneca
20-May-2021	Early amcenestrant data featured at ASCO support its potential to become a new endocrine backbone therapy for ER+/HER2- breast cancer	Sanofi
20-May-2021	Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting	Sanofi
20-May-2021	HUTCHMED Highlights Clinical Data to be Presented at the Upcoming ASCO21 Virtual Scientific Program	HUTCHMED (China) Limited
20-May-2021	Novo Holdings co-leads oversubscribed CHF 100 Million (USD 110 M) Series C in Numab Therapeutics	Novo Holdings
20-May-2021	SphingoTec Accelerates Growth with Direct Sales	SphingoTec
20-May-2021	Vertex announces EMA and MHRA regulatory applications for the use of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor in children 6-11 years old	Vertex
20-May-2021	Moderna to Establish an International Business Services Hub in Warsaw, Poland	Moderna
20-May-2021	NovalGen presents data at American Society of Clinical Oncology for novel ROR1xCD3 bispecific antibody for non-Hodgkin lymphoma	NovalGen
20-May-2021	AVENIR GLOBAL brings together four leading brands in new state-of-the-art space at Riverside House, London	AVENIR GLOBAL
20-May-2021	NHS invites people aged 34 and 35 for life-saving COVID-19 jab	NHS England
20-May-2021	Urgent assessment/treatment following ingestion of ‘super strong’ magnets	NHS England
20-May-2021	Manchester scientists accelerate path for making COVID-19 drugs	The University of Manchester
20-May-2021	Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center	Thermo Fisher Scientific and University of California
20-May-2021	HRA Pharma Rare Diseases: First prospective study extension confirms that metyrapone is effective and safe for treating endogenous Cushing’s Syndrome in the long term	HRA Pharma Rare Diseases
20-May-2021	Animal Artificial Insemination Market 2021 Industry Size & Share, Growth Opportunities, Competitive Landscape And Revenue Forecast By 2029 \| FMI Report with Expert Review	MARKITWIRED
20-May-2021	PARP Inhibitors Market Emerging Trend, Top Companies, Industry Demand and Regional Analysis by 2026 \| AstraZeneca, AbbVie, Clovis Oncology & so on…	MARKITWIRED
20-May-2021	Corneal Ulcer Treatment Market Trends 2021 \| SWOT Analysis, Demand, Growth, Segmentation, Outlook, Industry Report by 2029 \| FMI Report with Expert Review	MARKITWIRED